| Authors: |
Baraldi F; National Heart and Lung Institute, Imperial College London, London, UK.; University of Ferrara, Ferrara, Italy., Mah JSY; National Heart and Lung Institute, Imperial College London, London, UK., Almuhanna A; National Heart and Lung Institute, Imperial College London, London, UK., Braddy-Green A; National Heart and Lung Institute, Imperial College London, London, UK., Bartlett-Pestell S; National Heart and Lung Institute, Imperial College London, London, UK., MacLeod MA; National Heart and Lung Institute, Imperial College London, London, UK., Bloom CI; National Heart and Lung Institute, Imperial College London, London, UK., Ritchie AI; National Heart and Lung Institute, Imperial College London, London, UK.; Respiratory and Immunology Early Clinical development, AstraZeneca Plc, Cambridge, UK., Wiseman DJ; National Heart and Lung Institute, Imperial College London, London, UK.; Chelsea and Westminster NHS Foundation Trust., Allinson JP; National Heart and Lung Institute, Imperial College London, London, UK., Hoffman EA; University of Iowa, Iowa, USA., Papi A; University of Ferrara, Ferrara, Italy., Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, UK., Finney LJ; National Heart and Lung Institute, Imperial College London, London, UK. |
